Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Lightpoint, University of Arizona Enter into Cancer Imaging Agreement
May 2016
CHESHAM, England, May 23, 2016 — Medical device developer Lightpoint Medical Ltd. has entered into an exclusive global license agreement with the University of Arizona to develop molecular imaging technology.

Beta Emission Tomography, developed by professor Harrison Barrett, student Yijun Ding and Dr. Luca Caucci at the University of Arizona Center for Gamma Ray Imaging, enables the miniaturization of a positron emission tomography (PET) scanner for the operating room. The capability will be incorporated into Lightpoint’s image-guided cancer surgery product.

"Dr. Barrett's work in imaging technology represents a great advance in imaging for cancer surgery," said Doug Hockstad, senior director of technology transfer for Tech Launch Arizona, a University of Arizona office that works to commercialize university research. "This collaboration with Lightpoint is an ideal way to move this important work from the world of research out to where it can directly impact patient care.”

Lightpoint aims to guide cancer surgery in real time to improve health outcomes for patients.

BusinesspartnershipsAmericasEnglandEuropeArizonapeopleHarrison barrettluca caucciyijun dingbeta emission tomographyeducationPETmedicalBiophotonicscancerimaginglicensingcommercialization

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.